FranceHealthcare and life sciences2023 – ongoingSanofi
AI selection of lipid nanoparticles for mRNA delivery
Sanofi reported cutting lipid nanoparticle prediction from months to days
Problem
Sanofi needed stable lipid nanoparticles to carry mRNA vaccines into their intended cells. Selecting suitable particles from its library took months.
Approach
R&D teams used AI to build digital models that predicted promising particles from Sanofi's library. Sanofi reported that the prediction process took days after introducing AI.
Results
Takeaway
The reported time saving covered particle prediction. Sanofi did not report a corresponding reduction in vaccine development time.
Categories
- Size
- Large enterprise
- Industry
- Healthcare and life sciences
- Business function
- IT and R&D
- Innovation type
- Process innovation
- AI technology
- Predictive analytics and ML
- Adoption
- Built in-house
- Evidence
- Company's own claim
Sources
Source summaries
Sanofi described AI models used to select lipid nanoparticles for mRNA delivery. It said prediction time fell from months to days.
Full details are in the original sources.
